Articles Tagged: Multigene Panel Testing
July 31, 2026
Hereditary Cancer Testing Menu Enhancements–May 2026
Our latest hereditary cancer menu enhancements are now available! Ambry is dedicated to the search for new, evidence-backed insights that can meaningfully impact patient…
Genetic Testing
Hereditary Cancer
Multigene Panel Testing
April 22, 2025
April 2025 Hereditary Cancer Menu and Reporting Updates
Explains in detail the Hereditary Cancer Menu and Reporting Updates from April 2025.
Colorectal Cancer
Genetic Testing
Hereditary Cancer
Multigene Panel Testing
December 17, 2024
Navigating Hereditary Cancer Testing: Selecting the Right Multigene Panel
For healthcare providers, choosing the right hereditary cancer test and laboratory is crucial to offer the best care for their patients.
Genetic Testing
Hereditary Cancer
Multigene Panel Testing
November 15, 2024
How the Ambry Patient for Life™ Program Minimizes the Need for Provider-Initiated Exome Reanalysis Requests
One of the unique benefits of exome testing is the ability to return to the data from the initial analysis and reevaluate it for new,…
Genetic Testing
Genetic Testing Accuracy
Multigene Panel Testing
Tag
VUS
Whole Exome Sequencing
October 31, 2024
Striking the Perfect Balance in Designing Hereditary Cancer Tests: The Ambry Approach
Ambry’s balanced approach to designing hereditary cancer tests ensures our panels remain relevant and impactful, helping clinicians manage hereditary cancer risk with confidence.
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Variant of Unknown Significance
VUS
October 17, 2024
The Evolution of Hereditary Cancer Testing: Why Pan-Cancer Panels Are the Future of Genetic Risk Assessment
Pan-cancer panels offer more comprehensive diagnoses, personalized risk assessments, and targeted prevention and treatment strategies.
BRCA1 & 2
Genetic Testing
Genetic Testing Accuracy
Hereditary Cancer
Multigene Panel Testing
Ovarian Cancer
Variant of Unknown Significance
VUS